BRD2 and Alzheimer disease: With that said, our findings provide a unique genetics–based framework for FSH inhibition to prevent AD–like features in people, particularly in women across the menopausal transition where deficits in memory and MCI are associated with rapid bone loss and the onset of visceral obesity15, 18, 19.